Truist Securities Maintains Buy on Hinge Health, Raises Price Target to $112
Truist Securities analyst Jailendra Singh maintains Hinge Health (NYSE: HNGE ) with a Buy and raises the price target from $85 to $112.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.